In individuals with mild cognitive impairment (MCI) or dementia, evidence of cerebral amyloid and tau accumulation accompanying neurodegeneration is necessary to confirm the diagnosis of Alzheimer’s disease (AD)1. Here, MAPT is linked to Alzheimer disease.